Cargando…

Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Detalles Bibliográficos
Autores principales: Beusekamp, Joost C., Tromp, Jasper, Boorsma, Eva M., Heerspink, Hiddo J.L., Damman, Kevin, Voors, Adriaan A., van der Meer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360090/
https://www.ncbi.nlm.nih.gov/pubmed/33899306
http://dx.doi.org/10.1002/ejhf.2197
_version_ 1783737674124754944
author Beusekamp, Joost C.
Tromp, Jasper
Boorsma, Eva M.
Heerspink, Hiddo J.L.
Damman, Kevin
Voors, Adriaan A.
van der Meer, Peter
author_facet Beusekamp, Joost C.
Tromp, Jasper
Boorsma, Eva M.
Heerspink, Hiddo J.L.
Damman, Kevin
Voors, Adriaan A.
van der Meer, Peter
author_sort Beusekamp, Joost C.
collection PubMed
description
format Online
Article
Text
id pubmed-8360090
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83600902021-08-17 Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure Beusekamp, Joost C. Tromp, Jasper Boorsma, Eva M. Heerspink, Hiddo J.L. Damman, Kevin Voors, Adriaan A. van der Meer, Peter Eur J Heart Fail Research Letters John Wiley & Sons, Ltd. 2021-05-11 2021-06 /pmc/articles/PMC8360090/ /pubmed/33899306 http://dx.doi.org/10.1002/ejhf.2197 Text en © 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letters
Beusekamp, Joost C.
Tromp, Jasper
Boorsma, Eva M.
Heerspink, Hiddo J.L.
Damman, Kevin
Voors, Adriaan A.
van der Meer, Peter
Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title_full Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title_fullStr Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title_full_unstemmed Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title_short Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
title_sort effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360090/
https://www.ncbi.nlm.nih.gov/pubmed/33899306
http://dx.doi.org/10.1002/ejhf.2197
work_keys_str_mv AT beusekampjoostc effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT trompjasper effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT boorsmaevam effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT heerspinkhiddojl effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT dammankevin effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT voorsadriaana effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure
AT vandermeerpeter effectsofsodiumglucosecotransporter2inhibitionwithempagliflozinonpotassiumhandlinginpatientswithacuteheartfailure